Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the composite neonatal adverse outcomes (CNAO) among pregnancies complicated by fetal growth restriction (FGR) managed using the Society of Maternal-Fetal Medic...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of Texas Health Science Center, Houston
NCT05651347 · Fetal Growth Retardation, Stillbirth and Fetal Death, and more
NCT06952777 · Fetal Distress With Antenatal Problem, Fetal Growth Retardation
NCT04720690 · Arterial Stiffness, Fetal Growth Retardation, and more
NCT05952583 · Twin; Pregnancy, Affecting Fetus or Newborn, Fetal Growth Retardation, and more
NCT05038462 · Fetal Growth Retardation, Intrauterine Growth Restriction
The University of Texas Health Science Center at Houston
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions